Cognition Therapeutics Inc banner

Cognition Therapeutics Inc
NASDAQ:CGTX

Watchlist Manager
Cognition Therapeutics Inc Logo
Cognition Therapeutics Inc
NASDAQ:CGTX
Watchlist
Price: 0.868 USD -2.63% Market Closed
Market Cap: $76.6m

Profitability Summary

Cognition Therapeutics Inc's profitability score is 21/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

21 / 100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

21 / 100
Profitability
Score
21 / 100
Profitability
Score

Margins

Earnings Waterfall
Cognition Therapeutics Inc

Margins Comparison
Cognition Therapeutics Inc Competitors

Country Company Market Cap Operating
Margin
Net
Margin
US
Cognition Therapeutics Inc
NASDAQ:CGTX
77.2m USD
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
883.9B USD
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
585.2B USD
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.5B GBP
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
299.1B USD
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
235.8B CHF
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
161B USD
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
120B USD
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Cognition Therapeutics Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Cognition Therapeutics Inc
NASDAQ:CGTX
77.2m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
883.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
585.2B USD
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.5B GBP
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
299.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
235.8B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
237.1B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
161B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
120B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Cognition Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett